NeuroPace Inc (NPCE) - Product Pipeline Analysis, 2026 Update
Description
Summary
NeuroPace Inc (NeuroPace) is a medical device company that focuses on developing innovative solutions for epilepsy treatment. The company offers brain-responsive neurostimulation systems designed to reduce or eliminate seizures. Its major product is the RNS System, a brain-responsive platform that provides personalized, real-time treatment for epilepsy. NeuroPace's products are primarily used by healthcare providers to treat patients with epilepsy. The company collaborates with various healthcare centers and professionals to distribute its products. It targets markets in regions where there is a significant need for advanced epilepsy treatments. NeuroPace is headquartered in Mountain View, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
NeuroPace Inc (NeuroPace) is a medical device company that focuses on developing innovative solutions for epilepsy treatment. The company offers brain-responsive neurostimulation systems designed to reduce or eliminate seizures. Its major product is the RNS System, a brain-responsive platform that provides personalized, real-time treatment for epilepsy. NeuroPace's products are primarily used by healthcare providers to treat patients with epilepsy. The company collaborates with various healthcare centers and professionals to distribute its products. It targets markets in regions where there is a significant need for advanced epilepsy treatments. NeuroPace is headquartered in Mountain View, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NeuroPace Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
35 Pages
- NeuroPace Inc Company Overview
- NeuroPace Inc Company Snapshot
- NeuroPace Inc Pipeline Products and Ongoing Clinical Trials Overview
- NeuroPace Inc – Pipeline Analysis Overview
- NeuroPace Inc - Key Facts
- NeuroPace Inc - Major Products and Services
- NeuroPace Inc Pipeline Products by Development Stage
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
- NeuroPace Inc Pipeline Products Overview
- NeuroPace RNS System - Adolescents
- NeuroPace RNS System - Adolescents Product Overview
- NeuroPace RNS System - Idiopathic Generalized Epilepsy
- NeuroPace RNS System - Idiopathic Generalized Epilepsy Product Overview
- NeuroPace RNS System - Idiopathic Generalized Epilepsy Clinical Trial
- NeuroPace RNS System - Lennox Gastaut Syndrome
- NeuroPace RNS System - Lennox Gastaut Syndrome Product Overview
- SeizureID
- SeizureID Product Overview
- NeuroPace Inc - Key Competitors
- NeuroPace Inc - Key Employees
- NeuroPace Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- NeuroPace Inc, Recent Developments
- Mar 05, 2026: NeuroPace to Present at the Leerink Global Healthcare Conference
- Feb 20, 2026: NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
- Jan 13, 2026: NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
- Dec 17, 2025: NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS System Indication for Idiopathic Generalized Epilepsy
- Dec 08, 2025: NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
- Dec 02, 2025: Neuropace To Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting
- Nov 24, 2025: NeuroPace Announces Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
- Nov 24, 2025: NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
- Aug 28, 2025: NeuroPace to Participate in Upcoming Healthcare Conferences
- Aug 01, 2025: Neuropace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy With Neurostimulator Cases
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- NeuroPace Inc Pipeline Products and Ongoing Clinical Trials Overview
- NeuroPace Inc Pipeline Products by Equipment Type
- NeuroPace Inc Pipeline Products by Indication
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
- NeuroPace Inc, Key Facts
- NeuroPace Inc, Major Products and Services
- NeuroPace Inc Number of Pipeline Products by Development Stage
- NeuroPace Inc Pipeline Products Summary by Development Stage
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
- NeuroPace Inc Ongoing Clinical Trials Summary
- NeuroPace RNS System - Adolescents - Product Status
- NeuroPace RNS System - Adolescents - Product Description
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - Product Status
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - Product Description
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - Mapping Algorithmic State Space in the Human Brain
- NeuroPace RNS System - Idiopathic Generalized Epilepsy - RNS System NAUTILUS Study (NAUTILUS)
- NeuroPace RNS System - Lennox Gastaut Syndrome - Product Status
- NeuroPace RNS System - Lennox Gastaut Syndrome - Product Description
- SeizureID - Product Status
- SeizureID - Product Description
- NeuroPace Inc, Key Employees
- Glossary
- List of Figures
- NeuroPace Inc Pipeline Products by Equipment Type
- NeuroPace Inc Pipeline Products by Development Stage
- NeuroPace Inc Ongoing Clinical Trials by Trial Status
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
